Pasar al contenido principal

ESTUDIOS GENETICOS Y FUNCIONALES HACIA APROXIMACIONES TERAPEUTICAS PARA VARIAS ENFERMEDADES OSEAS Y SINDROMES DE DISCAPACIDAD INTELECTUAL

PID2019-107188RB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 19
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures

  • Garcia Giralt, Natàlia
  • Ovejero Crespo, Diana
  • Grinberg, Daniel
  • Nogués Solán, Xavier
  • Castañeda, Santos
  • Balcells, Susana
  • Rabionet Janssen, Raquel
Background: Recent studies suggested that genetic variants associated with monogenic bone disorders were involved in the pathogenesis of atypical femoral fractures (AFF). Here, we aim to identify rare genetic variants by whole exome sequencing in genes involved in monogenic rare skeletal diseases in 12 women with AFF and 4 controls without any fracture. Results: Out of 33 genetic variants identified in women with AFF, eleven (33.3%) were found in genes belonging to the Wnt pathway (LRP5, LRP6, DAAM2, WNT1, and WNT3A). One of them was rated as pathogenic (p.Pro582His in DAAM2), while all others were rated as variants of uncertain significance according to ClinVar and ACMG criteria. Conclusions: Osteoporosis, rare bone diseases, and AFFs may share the same genes, thus making it even more difficult to identify unique risk factors., This research was funded by Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (grant number CB16/10/00245); Fundación Española de Investigación Ósea y del Metabolismo Mineral (FEIOMM); Fondo de Investigación en Salud (grant number PI19/00033) from Instituto de Salud Carlos III (ISCIII) and European Union Fund. The research was also supported by MCIN/AEI/https://doi.org/10.13039/501100011033, Project PID2019-107188RB-C21, and AGAUR. DO is recipient of a Miquel Servet grant from ISCIII.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women

  • Patiño, Juan David
  • Ovejero Crespo, Diana
  • Gabernet, Marc
  • Martínez-Gil, Núria
  • Alcaide-Consuegra, Estefanía
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Grinberg, Daniel
  • Balcells, Susana
  • Rabionet Janssen, Raquel
  • Garcia Giralt, Natàlia
Rare genetic variants in genes previously described to be involved in bone monogenic disorders were identified in postmenopausal women split into two groups according to extreme bone mineral density (BMD) values and lumbar spine Z-scores. A pathogenic variant in COL1A2 gene found in a woman with low BMD highlights the overlap between osteogenesis imperfecta and osteoporosis, which may share their genetic etiology. Other variants were not clearly associated with the extreme BMD, suggesting that there is little contribution of rare variants to postmenopausal osteoporosis. Purpose: We aimed to evaluate whether extreme values of bone mineral density (BMD) in a population-based cohort of postmenopausal women (BARCOS) could be determined by rare genetic variants in genes related to monogenic bone disorders. Methods: A panel of 127 genes related to different skeletal phenotypes was designed. Massive sequencing by targeted capture of these genes was performed in 104 DNA samples from those women of the BARCOS cohort that exhibited the highest (HZ group) and lowest (LZ group) LS Z-scores, ranging from + 0.70 to + 3.80 and from - 2.35 to - 4.26, respectively. 5'UTR, 3'UTR, splice region, missense, nonsense, and short indel variants with MAF < 0.01 were annotated with CADD version 1.6 and considered in the analysis. Results: After filtering those variants with CADD > 25 and present only in one of the groups (either LZ or HZ), six variants were detected, most of which (5/6) were in the LZ group in TCIRG1, COL1A2, SEC24D, LRP4, and ANO5 genes, while only one, in the LMNA gene, was in the HZ group. According to the ClinVar database, the COL1A2 variant, causative of a recessive form of osteogenesis imperfecta, is described as pathogenic, while the other variants are considered of uncertain significance (VUS). Conclusion: The variant identified in COL1A2 in a woman from the LZ group highlights the genetic overlap between monogenic diseases such as osteogenesis imperfecta and complex diseases like osteoporosis. However, the other variants were not clearly associated with the extreme BMD, suggesting that there is little contribution of rare variants to postmenopausal osteoporosis., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Funds for the study include grants PID2019-107188RB-C21 (Spanish MICINN) and CIBERER (U720). JDP was a recipient of the FI-SDUR predoctoral fellowship from Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR). The research was also supported by the Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (grant number CB16/10/00245) and European Union Fund. DO is recipient of a Miquel Servet grant from ISCIII.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Functional analyses of four CYP1A1 missense mutations present in patients with atypical femoral fractures

  • Ugartondo, Nerea
  • Martínez-Gil, Núria
  • Esteve, Mònica
  • Garcia Giralt, Natàlia
  • Roca Ayats, Neus
  • Ovejero Crespo, Diana
  • Nogués Solán, Xavier
  • Diez Pérez, Adolfo
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Osteoporosis is the most common metabolic bone disorder and nitrogen-containing bisphosphonates (BP) are a first line treatment for it. Yet, atypical femoral fractures (AFF), a rare adverse effect, may appear after prolonged BP administration. Given the low incidence of AFF, an underlying genetic cause that increases the susceptibility to these fractures is suspected. Previous studies uncovered rare CYP1A1 mutations in osteoporosis patients who suffered AFF after long-term BP treatment. CYP1A1 is involved in drug metabolism and steroid catabolism, making it an interesting candidate. However, a functional validation for the AFF-associated CYP1A1 mutations was lacking. Here we tested the enzymatic activity of four such CYP1A1 variants, by transfecting them into Saos-2 cells. We also tested the effect of commonly used BPs on the enzymatic activity of the CYP1A1 forms. We demonstrated that the p.Arg98Trp and p.Arg136His CYP1A1 variants have a significant negative effect on enzymatic activity. Moreover, all the BP treatments decreased CYP1A1 activity, although no specific interaction with CYP1A1 variants was found. Our results provide functional support to the hypothesis that an additive effect between CYP1A1 heterozygous mutations p.Arg98Trp and p.Arg136His, other rare mutations and long-term BP exposure might generate susceptibility to AFF., Funding was available from Fundación Española de Investigación Ósea y Metabolismo Mineral (“Beca FEIOMM 2019 de Investigación Básica”) and grant PID2019-107188RB-C21 from the Spanish Ministerio de Ciencia e Innovación. N.M.G. and N.R.A. were recipients of Ph.D. fellowships from AGAUR (Catalan Government) and the Spanish Ministerio de Universidades.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Evolutionary and functional analyses of LRP5 in archaic and extant modern humans

  • Roca Ayats, Neus
  • Maceda Porto, Iago, 1986-
  • Bruque, Carlos David
  • Martínez-Gil, Núria
  • Garcia Giralt, Natàlia
  • Cozar, Mónica
  • Mellibovsky, Leonardo
  • Van Hul, Wim
  • Lao Grueso, Oscar, 1976-
  • Grinberg, Daniel
  • Balcells, Susana
Background: The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced. Results: We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation. Conclusions: In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations., NRA, NMG, MC, DG and SB acknowledge the financial support from Spanish Ministry of Science and Innovation (SAF 2016-75948R and PID2019-107188RB-C21) and Catalan Government (2017SGR:00738). NRA was a recipient of a FPU predoctoral fellowship from the Spanish Minsterio de Educación Cultura y Deporte. NMG was a recipient of a FI predoctoral fellowship from AGAUR (Catalan Agency for Management of University and Research Grants). OL and IM acknowledge the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020. OL gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937 and CSIC (Proyecto Intramural 2022). IM gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d’Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants)—GRC 2014 SGR 615.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Regulation of WNT16 in bone may involve upstream enhancers within CPED1

  • Martínez-Gil, Núria
  • Herrera-Úbeda, Carlos
  • Gritti, Nicola
  • Roca Ayats, Neus
  • Ugartondo, Nerea
  • Garcia Giralt, Natàlia
  • Ovejero Crespo, Diana
  • Nogués Solán, Xavier
  • Garcia-Fernàndez, Jordi
  • Grinberg, Daniel
  • Balcells, Susana
WNT16 stands up as an essential gene for bone homeostasis. Here, we present new evidence of the functional role of a particular region within WNT16. Performing 4 C chromatin conformation analysis in three osteoblast-related cells (the human fetal osteoblast hFOB 1.19 cell line, Saos 2 osteosarcoma cell line and mesenchymal Stem Cells -MSC-), we identify physical interactions between the proximal part of WNT16 intron 2, shown here to be an active promoter in Saos 2 osteosarcoma cells, and several putative regulatory regions within CPED1. Analysis of previously published RNA-seq data from hFOB cells disclosed low expression of a region located downstream of this promoter. Our results suggest a novel regulatory mechanism of WNT16 in bone, mediated by physical interaction with various enhancer regions within CPED1., Funds for the study include grants PID2019-107188RB-C21, PID2020-117820GB-I00, PID2022-141461OB-I00, PID2023-146794NB-I00 and BFU2017-86152-P (Spanish MINECO), 2021SGR: 01093 (AGAUR, Catalan Government) and CIBERER (U720). NMG was a recipient of a FI predoctoral fellowship from Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR); NRA was a recipient of a FPU and CHU of a FPI predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders

  • Formosa, Melissa M.
  • Bergen, Dylan J.M.
  • Gregson, Celia L.
  • Maurizi, Antonio
  • Kämpe, Anders
  • Garcia Giralt, Natàlia
  • Zhou, Wei
  • Grinberg, Daniel
  • Ovejero Crespo, Diana
  • Zillikens, M. Carola
  • Williams, Graham R.
  • Bassett, J.H. Duncan
  • Brandi, María Luisa
  • Sangiorgi, Luca
  • Balcells, Susana
  • Högler, Wolfgang
  • Van Hul, Wim
  • Mäkitie, Outi
Genetic disorders of the skeleton encompass a diverse group of bone diseases differing in clinical characteristics, severity, incidence and molecular etiology. Of particular interest are the monogenic rare bone mass disorders, with the underlying genetic defect contributing to either low or high bone mass phenotype. Extensive, deep phenotyping coupled with high-throughput, cost-effective genotyping is crucial in the characterization and diagnosis of affected individuals. Massive parallel sequencing efforts have been instrumental in the discovery of novel causal genes that merit functional validation using in vitro and ex vivo cell-based techniques, and in vivo models, mainly mice and zebrafish. These translational models also serve as an excellent platform for therapeutic discovery, bridging the gap between basic science research and the clinic. Altogether, genetic studies of monogenic rare bone mass disorders have broadened our knowledge on molecular signaling pathways coordinating bone development and metabolism, disease inheritance patterns, development of new and improved bone biomarkers, and identification of novel drug targets. In this comprehensive review we describe approaches to further enhance the innovative processes taking discoveries from clinic to bench, and then back to clinic in rare bone mass disorders. We highlight the importance of cross laboratory collaboration to perform functional validation in multiple model systems after identification of a novel disease gene. We describe the monogenic forms of rare low and high rare bone mass disorders known to date, provide a roadmap to unravel the genetic determinants of monogenic rare bone mass disorders using proper phenotyping and genotyping methods, and describe different genetic validation approaches paving the way for future treatments., Funding was obtained from the GEMSTONE COST Action (CA18139). MMF has received research funds from The University of Malta Research, Innovation and Development Trust and The Malta Community Chest Fund, and the Research Excellence Programme (REP-2020-011; Project GeOM financed by the Malta Council for Science & Technology, for and on behalf of the Foundation for Science and Technology, through the Research Excellence Programme). DB is funded by the Foundation Fellowship from Versus Arthritis (Grant no. 22044). NG-G and DC are supported by CIBERFES (CB16/10/00245 [ISCIII]), FEIOMM2019 and European Regional Development Fund (ERDF). WZ is funded by the Jaap Schouten Foundation (The Netherlands). WVH received a Methusalem-OEC grant for the project “GENOMED” and a Research Fund of the University of Antwerp (FFB190208). MB has received funding from La Fondazione Italiana Ricerca sulle Malattie dell’Osso. The Origins of Bone and Cartilage Disease Programme analysed the skeletal phenotype of knockout mice generated by the International Mouse Phenotyping Consortium (IMPC) and was funded by a Wellcome Trust Strategic Award (101123) to GW and JB. OM is funded by the Sigrid Jusélius Foundation. DG and SB declare that this study received funding from MINECO (SAF2016-75948R and PID2019-107188RB-C21). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

On the association between Chiari malformation type 1, bone mineral density and bone related genes

  • Martínez-Gil, Núria
  • Mellibovsky, Leonardo
  • Manzano-López González, Demián
  • Patiño, Juan David
  • Cozar, Mónica
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Background: Chiari malformation type 1 (C1M) is a neurological disease characterized by herniation of the cerebellar tonsils below the foramen magnum. Cranial bone constriction is suspected to be its main cause. To date, genes related to bone development (e.g. DKK1 or COL1A2) have been associated with C1M, while some bone diseases (e.g. Paget) have been found to cosegregate with C1M. Nevertheless, the association between bone mineral density (BMD) and C1M has not been investigated, yet. Here, we systematically investigate the association between C1M and BMD, and between bone related genes and C1M. Methods: We have recruited a small cohort of C1M patients (12 unrelated patients) in whom we have performed targeted sequencing of an in-house bone-related gene panel and BMD determination through non-invasive DXA. Results: In the search for association between the bone related genes and C1M we have found variants in more than one C1M patient in WNT16, CRTAP, MYO7A and NOTCH2. These genes have been either associated with craniofacial development in different ways, or previously associated with C1M (MYO7A). Regarding the potential link between BMD and C1M, we have found three osteoporotic patients and one patient who had high BMD, very close to the HBM phenotype values, although most patients had normal BMD. Conclusions: Variants in bone related genes have been repeatedly found in some C1M cases. The relationship of bone genes with C1M deserves further study, to get a clearer estimate of their contribution to its etiology. No direct correlation between BMD and C1M was observed., Funds for the study include grants PID2019-107188RB-C21 (Spanish MICINN) and CIBERER (U720). NMG and JDP were recipients of FI and FI-SDUR predoctoral fellowships from Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), respectively.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Genetic analysis in a familial case with high bone mineral density suggests additive effects at two loci

  • Martínez-Gil, Núria
  • Ovejero Crespo, Diana
  • Garcia Giralt, Natàlia
  • Bruque, Carlos David
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Osteoporosis is the most common bone disease, characterized by a low bone mineral density (BMD) and increased risk of fracture. At the other end of the BMD spectrum, some individuals present strong, fracture-resistant, bones. Both osteoporosis and high BMD are heritable and their genetic architecture encompasses polygenic inheritance of common variants and some cases of monogenic highly penetrant variants in causal genes. We have investigated the genetics of high BMD in a family segregating this trait in an apparently Mendelian dominant pattern. We searched for rare causal variants by whole-exome sequencing in three affected and three nonaffected family members. Using this approach, we have identified 38 rare coding variants present in the proband and absent in the three individuals with normal BMD. Although we have found four variants shared by the three affected members of the family, we have not been able to relate any of these to the high-BMD phenotype. In contrast, we have identified missense variants in two genes, VAV3 and ADGRE5, each shared by two of out of three affected members, whose loss of function fits with the phenotype of the family. In particular, the proband, a woman displaying the highest BMD (sum Z-score = 7), carries both variants, whereas the other two affected members carry one each. VAV3 encodes a guanine-nucleotide-exchange factor with an important role in osteoclast activation and function. Although no previous cases of VAV3 mutations have been reported in humans, Vav3 knockout (KO) mice display dense bones, similarly to the high-BMD phenotype present in our family. The ADGRE5 gene encodes an adhesion G protein-coupled receptor expressed in osteoclasts whose KO mouse displays increased trabecular bone volume. Combined, these mouse and human data highlight VAV3 and ADGRE5 as novel putative high-BMD genes with additive effects, and potential therapeutic targets for osteoporosis. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., Funds for the study include grants SAF2016-75948-R (Spanish MINECO), PID2019-107188RB-C21 (MICINN) and CIBERER (U720), CIBERFES (CB16/10/00245), and European Regional Development Fund for the whole project. We thank Mónica Cózar for technical assistance and the family for their enthusiastic participation.Authors' roles: NMG was involved in conceptualization, data curation, formal analysis, investigation, methodology, writing-original draft, and review & editing. CDB was involved in data curation, formal analysis, methodology, and review & editing. RR, DG, and SB were involved in conceptualization, funding acquisition, investigation, supervision, writing-original draft, and review & editing. DO and NGG were involved in investigation, data curation, and writing-review & editing. XN and LM were involved in conceptualization, data curation, and writing-review & editing.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Gene network of susceptibility to atypical femoral fractures related to bisphosphonate treatment

  • Garcia Giralt, Natàlia
  • Roca Ayats, Neus
  • Abril Ferrando, Josep Francesc
  • Martínez-Gil, Núria
  • Ovejero Crespo, Diana
  • Castañeda, Santos
  • Nogués Solán, Xavier
  • Grinberg, Daniel
  • Balcells, Susana
  • Rabionet Janssen, Raquel
Atypical femoral fractures (AFF) are rare fragility fractures in the subtrocantheric or diaphysis femoral region associated with long-term bisphosphonate (BP) treatment. The etiology of AFF is still unclear even though a genetic basis is suggested. We performed whole exome sequencing (WES) analysis of 12 patients receiving BPs for at least 5 years who sustained AFFs and 4 controls, also long-term treated with BPs but without any fracture. After filtration and prioritization of rare variants predicted to be damaging and present in genes shared among at least two patients, a total of 272 variants in 132 genes were identified. Twelve of these genes were known to be involved in bone metabolism and/or AFF, highlighting DAAM2 and LRP5, both involved in the Wnt pathway, as the most representative. Afterwards, we intersected all mutated genes with a list of 34 genes obtained from a previous study of three sisters with BP-related AFF, identifying nine genes. One of these (MEX3D) harbored damaging variants in two AFF patients from the present study and one shared among the three sisters. Gene interaction analysis using the AFFNET web suggested a complex network among bone-related genes as well as with other mutated genes. BinGO biological function analysis highlighted cytoskeleton and cilium organization. In conclusion, several genes and their interactions could provide genetic susceptibility to AFF, that along with BPs treatment and in some cases with glucocorticoids may trigger this so feared complication., This research was funded by MCIN/AEI/10.13039/501100011033, Project PID2019-107188RB-C21. The research was also supported by Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (grants number CB16/10/00245); Fundación Española de Investigación Ósea y del Metabolismo Mineral (FEIOMM); Formación en Investigación en Salud (grant number PI19/00033) from Instituto de Salud Carlos III (ISCIII); and European Regional Development Fund. DO is recipient of a Sara Borrell grant from ISCIII.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolutionary and functional analyses of LRP5 in archaic and extant modern humans

  • Roca-Ayats, Neus
  • Maceda, Iago
  • Bruque, Carlos David
  • Martínez-Gil, Núria
  • Garcia-Giralt, Natàlia
  • Cozar, Mónica
  • Mellibovsky, Leonardo
  • Van Hul, Wim
  • Lao, Oscar
  • Grinberg, Daniel
  • Balcells, Susanna
[Background] The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced., [Results] We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation., [Conclusions] In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations., NRA, NMG, MC, DG and SB acknowledge the financial support from Spanish Ministry of Science and Innovation (SAF 2016-75948R and PID2019-107188RB-C21) and Catalan Government (2017SGR:00738). NRA was a recipient of a FPU predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte. NMG was a recipient of a FI predoctoral fellowship from AGAUR (Catalan Agency for Management of University and Research Grants). OL and IM acknowledge the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020. OL gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937 and CSIC (Proyecto Intramural 2022). IM gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d’Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants)—GRC 2014 SGR 615., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

On the association between Chiari malformation type 1, bone mineral density and bone related genes

  • Martínez-Gil, Núria
  • Mellibovsky, Leonardo
  • Manzano-López González, Demián
  • Patiño, Juan David
  • Cozar, Mónica
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Background: Chiari malformation type 1 (C1M) is a neurological disease characterized by herniation of the cerebellar tonsils below the foramen magnum. Cranial bone constriction is suspected to be its main cause. To date, genes related to bone development (e.g. DKK1 or COL1A2) have been associated with C1M, while some bone diseases (e.g. Paget) have been found to cosegregate with C1M. Nevertheless, the association between bone mineral density (BMD) and C1M has not been investigated, yet. Here, we systematically investigate the association between C1M and BMD, and between bone related genes and C1M. Methods: We have recruited a small cohort of C1M patients (12 unrelated patients) in whom we have performed targeted sequencing of an in-house bone-related gene panel and BMD determination through non-invasive DXA. Results: In the search for association between the bone related genes and C1M we have found variants in more than one C1M patient in WNT16, CRTAP, MYO7A and NOTCH2. These genes have been either associated with craniofacial development in different ways, or previously associated with C1M (MYO7A). Regarding the potential link between BMD and C1M, we have found three osteoporotic patients and one patient who had high BMD, very close to the HBM phenotype values, although most patients had normal BMD. Conclusions: Variants in bone related genes have been repeatedly found in some C1M cases. The relationship of bone genes with C1M deserves further study, to get a clearer estimate of their contribution to its etiology. No direct correlation between BMD and C1M was observed., Funds for the study include grants PID2019-107188RB-C21 (Spanish MICINN) and CIBERER (U720). NMG and JDP were recipients of FI and FI-SDUR predoctoral fellowships from Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR), respectively.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Gene network of susceptibility to atypical femoral fractures related to bisphosphonate treatment

  • Garcia Giralt, Natàlia
  • Roca Ayats, Neus
  • Abril Ferrando, Josep Francesc
  • Martínez-Gil, Núria
  • Ovejero Crespo, Diana
  • Castañeda, Santos
  • Nogués Solán, Xavier
  • Grinberg, Daniel
  • Balcells, Susana
  • Rabionet Janssen, Raquel
Atypical femoral fractures (AFF) are rare fragility fractures in the subtrocantheric or diaphysis femoral region associated with long-term bisphosphonate (BP) treatment. The etiology of AFF is still unclear even though a genetic basis is suggested. We performed whole exome sequencing (WES) analysis of 12 patients receiving BPs for at least 5 years who sustained AFFs and 4 controls, also long-term treated with BPs but without any fracture. After filtration and prioritization of rare variants predicted to be damaging and present in genes shared among at least two patients, a total of 272 variants in 132 genes were identified. Twelve of these genes were known to be involved in bone metabolism and/or AFF, highlighting DAAM2 and LRP5, both involved in the Wnt pathway, as the most representative. Afterwards, we intersected all mutated genes with a list of 34 genes obtained from a previous study of three sisters with BP-related AFF, identifying nine genes. One of these (MEX3D) harbored damaging variants in two AFF patients from the present study and one shared among the three sisters. Gene interaction analysis using the AFFNET web suggested a complex network among bone-related genes as well as with other mutated genes. BinGO biological function analysis highlighted cytoskeleton and cilium organization. In conclusion, several genes and their interactions could provide genetic susceptibility to AFF, that along with BPs treatment and in some cases with glucocorticoids may trigger this so feared complication., This research was funded by MCIN/AEI/10.13039/501100011033, Project PID2019-107188RB-C21. The research was also supported by Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (grants number CB16/10/00245); Fundación Española de Investigación Ósea y del Metabolismo Mineral (FEIOMM); Formación en Investigación en Salud (grant number PI19/00033) from Instituto de Salud Carlos III (ISCIII); and European Regional Development Fund. DO is recipient of a Sara Borrell grant from ISCIII.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Evolutionary and functional analyses of LRP5 in archaic and extant modern humans

  • Roca Ayats, Neus
  • Maceda Porto, Iago, 1986-
  • Bruque, Carlos David
  • Martínez-Gil, Núria
  • Garcia Giralt, Natàlia
  • Cozar, Mónica
  • Mellibovsky, Leonardo
  • Van Hul, Wim
  • Lao Grueso, Oscar, 1976-
  • Grinberg, Daniel
  • Balcells, Susana
Background: The human lineage has undergone a postcranial skeleton gracilization (i.e. lower bone mass and strength relative to body size) compared to other primates and archaic populations such as the Neanderthals. This gracilization has been traditionally explained by differences in the mechanical load that our ancestors exercised. However, there is growing evidence that gracilization could also be genetically influenced. Results: We have analyzed the LRP5 gene, which is known to be associated with high bone mineral density conditions, from an evolutionary and functional point of view. Taking advantage of the published genomes of archaic Homo populations, our results suggest that this gene has a complex evolutionary history both between archaic and living humans and within living human populations. In particular, we identified the presence of different selective pressures in archaics and extant modern humans, as well as evidence of positive selection in the African and South East Asian populations from the 1000 Genomes Project. Furthermore, we observed a very limited evidence of archaic introgression in this gene (only at three haplotypes of East Asian ancestry out of the 1000 Genomes), compatible with a general erasing of the fingerprint of archaic introgression due to functional differences in archaics compared to extant modern humans. In agreement with this hypothesis, we observed private mutations in the archaic genomes that we experimentally validated as putatively increasing bone mineral density. In particular, four of five archaic missense mutations affecting the first β-propeller of LRP5 displayed enhanced Wnt pathway activation, of which two also displayed reduced negative regulation. Conclusions: In summary, these data suggest a genetic component contributing to the understanding of skeletal differences between extant modern humans and archaic Homo populations., NRA, NMG, MC, DG and SB acknowledge the financial support from Spanish Ministry of Science and Innovation (SAF 2016-75948R and PID2019-107188RB-C21) and Catalan Government (2017SGR:00738). NRA was a recipient of a FPU predoctoral fellowship from the Spanish Minsterio de Educación Cultura y Deporte. NMG was a recipient of a FI predoctoral fellowship from AGAUR (Catalan Agency for Management of University and Research Grants). OL and IM acknowledge the support from Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa, CERCA Program/Generalitat de Catalunya, Spanish Ministry of Science and Innovation through the Instituto de Salud Carlos III, Generalitat de Catalunya through Departament de Salut and Departament d’Empresa i Coneixement, Co-financing with funds from the European Regional Development Fund by the Spanish Ministry of Science and Innovation corresponding to the Programa Operativo FEDER Plurirregional de España (POPE) 2014–2020 and by the Secretaria d’Universitats i Recerca, Departament d’Empresa i Coneixement of the Generalitat de Catalunya corresponding to the Programa Operatiu FEDER de Catalunya 2014–2020. OL gratefully acknowledges the financial support from Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) PGC2018-098574-B-I00, Generalitat de Catalunya (Government of Catalonia)—GRC 2017 SGR 937 and CSIC (Proyecto Intramural 2022). IM gratefully acknowledges the financial support from the Government of Catalonia | Agència de Gestió d’Ajuts Universitaris i de Recerca (Agency for Management of University and Research Grants)—GRC 2014 SGR 615.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Genetic analysis in a familial case with high bone mineral density suggests additive effects at two loci

  • Martínez-Gil, Núria
  • Ovejero Crespo, Diana
  • Garcia Giralt, Natàlia
  • Bruque, Carlos David
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Osteoporosis is the most common bone disease, characterized by a low bone mineral density (BMD) and increased risk of fracture. At the other end of the BMD spectrum, some individuals present strong, fracture-resistant, bones. Both osteoporosis and high BMD are heritable and their genetic architecture encompasses polygenic inheritance of common variants and some cases of monogenic highly penetrant variants in causal genes. We have investigated the genetics of high BMD in a family segregating this trait in an apparently Mendelian dominant pattern. We searched for rare causal variants by whole-exome sequencing in three affected and three nonaffected family members. Using this approach, we have identified 38 rare coding variants present in the proband and absent in the three individuals with normal BMD. Although we have found four variants shared by the three affected members of the family, we have not been able to relate any of these to the high-BMD phenotype. In contrast, we have identified missense variants in two genes, VAV3 and ADGRE5, each shared by two of out of three affected members, whose loss of function fits with the phenotype of the family. In particular, the proband, a woman displaying the highest BMD (sum Z-score = 7), carries both variants, whereas the other two affected members carry one each. VAV3 encodes a guanine-nucleotide-exchange factor with an important role in osteoclast activation and function. Although no previous cases of VAV3 mutations have been reported in humans, Vav3 knockout (KO) mice display dense bones, similarly to the high-BMD phenotype present in our family. The ADGRE5 gene encodes an adhesion G protein-coupled receptor expressed in osteoclasts whose KO mouse displays increased trabecular bone volume. Combined, these mouse and human data highlight VAV3 and ADGRE5 as novel putative high-BMD genes with additive effects, and potential therapeutic targets for osteoporosis. © 2022 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research., Funds for the study include grants SAF2016-75948-R (Spanish MINECO), PID2019-107188RB-C21 (MICINN) and CIBERER (U720), CIBERFES (CB16/10/00245), and European Regional Development Fund for the whole project. We thank Mónica Cózar for technical assistance and the family for their enthusiastic participation.Authors' roles: NMG was involved in conceptualization, data curation, formal analysis, investigation, methodology, writing-original draft, and review & editing. CDB was involved in data curation, formal analysis, methodology, and review & editing. RR, DG, and SB were involved in conceptualization, funding acquisition, investigation, supervision, writing-original draft, and review & editing. DO and NGG were involved in investigation, data curation, and writing-review & editing. XN and LM were involved in conceptualization, data curation, and writing-review & editing.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Functional analyses of four CYP1A1 missense mutations present in patients with atypical femoral fractures

  • Ugartondo, Nerea
  • Martínez-Gil, Núria
  • Esteve, Mònica
  • Garcia Giralt, Natàlia
  • Roca Ayats, Neus
  • Ovejero Crespo, Diana
  • Nogués Solán, Xavier
  • Diez Pérez, Adolfo
  • Rabionet Janssen, Raquel
  • Grinberg, Daniel
  • Balcells, Susana
Osteoporosis is the most common metabolic bone disorder and nitrogen-containing bisphosphonates (BP) are a first line treatment for it. Yet, atypical femoral fractures (AFF), a rare adverse effect, may appear after prolonged BP administration. Given the low incidence of AFF, an underlying genetic cause that increases the susceptibility to these fractures is suspected. Previous studies uncovered rare CYP1A1 mutations in osteoporosis patients who suffered AFF after long-term BP treatment. CYP1A1 is involved in drug metabolism and steroid catabolism, making it an interesting candidate. However, a functional validation for the AFF-associated CYP1A1 mutations was lacking. Here we tested the enzymatic activity of four such CYP1A1 variants, by transfecting them into Saos-2 cells. We also tested the effect of commonly used BPs on the enzymatic activity of the CYP1A1 forms. We demonstrated that the p.Arg98Trp and p.Arg136His CYP1A1 variants have a significant negative effect on enzymatic activity. Moreover, all the BP treatments decreased CYP1A1 activity, although no specific interaction with CYP1A1 variants was found. Our results provide functional support to the hypothesis that an additive effect between CYP1A1 heterozygous mutations p.Arg98Trp and p.Arg136His, other rare mutations and long-term BP exposure might generate susceptibility to AFF., Funding was available from Fundación Española de Investigación Ósea y Metabolismo Mineral (“Beca FEIOMM 2019 de Investigación Básica”) and grant PID2019-107188RB-C21 from the Spanish Ministerio de Ciencia e Innovación. N.M.G. and N.R.A. were recipients of Ph.D. fellowships from AGAUR (Catalan Government) and the Spanish Ministerio de Universidades.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A roadmap to gene discoveries and novel therapies in monogenic low and high bone mass disorders

  • Formosa, Melissa M.
  • Bergen, Dylan J.M.
  • Gregson, Celia L.
  • Maurizi, Antonio
  • Kämpe, Anders
  • Garcia Giralt, Natàlia
  • Zhou, Wei
  • Grinberg, Daniel
  • Ovejero Crespo, Diana
  • Zillikens, M. Carola
  • Williams, Graham R.
  • Bassett, J.H. Duncan
  • Brandi, María Luisa
  • Sangiorgi, Luca
  • Balcells, Susana
  • Högler, Wolfgang
  • Van Hul, Wim
  • Mäkitie, Outi
Genetic disorders of the skeleton encompass a diverse group of bone diseases differing in clinical characteristics, severity, incidence and molecular etiology. Of particular interest are the monogenic rare bone mass disorders, with the underlying genetic defect contributing to either low or high bone mass phenotype. Extensive, deep phenotyping coupled with high-throughput, cost-effective genotyping is crucial in the characterization and diagnosis of affected individuals. Massive parallel sequencing efforts have been instrumental in the discovery of novel causal genes that merit functional validation using in vitro and ex vivo cell-based techniques, and in vivo models, mainly mice and zebrafish. These translational models also serve as an excellent platform for therapeutic discovery, bridging the gap between basic science research and the clinic. Altogether, genetic studies of monogenic rare bone mass disorders have broadened our knowledge on molecular signaling pathways coordinating bone development and metabolism, disease inheritance patterns, development of new and improved bone biomarkers, and identification of novel drug targets. In this comprehensive review we describe approaches to further enhance the innovative processes taking discoveries from clinic to bench, and then back to clinic in rare bone mass disorders. We highlight the importance of cross laboratory collaboration to perform functional validation in multiple model systems after identification of a novel disease gene. We describe the monogenic forms of rare low and high rare bone mass disorders known to date, provide a roadmap to unravel the genetic determinants of monogenic rare bone mass disorders using proper phenotyping and genotyping methods, and describe different genetic validation approaches paving the way for future treatments., Funding was obtained from the GEMSTONE COST Action (CA18139). MMF has received research funds from The University of Malta Research, Innovation and Development Trust and The Malta Community Chest Fund, and the Research Excellence Programme (REP-2020-011; Project GeOM financed by the Malta Council for Science & Technology, for and on behalf of the Foundation for Science and Technology, through the Research Excellence Programme). DB is funded by the Foundation Fellowship from Versus Arthritis (Grant no. 22044). NG-G and DC are supported by CIBERFES (CB16/10/00245 [ISCIII]), FEIOMM2019 and European Regional Development Fund (ERDF). WZ is funded by the Jaap Schouten Foundation (The Netherlands). WVH received a Methusalem-OEC grant for the project “GENOMED” and a Research Fund of the University of Antwerp (FFB190208). MB has received funding from La Fondazione Italiana Ricerca sulle Malattie dell’Osso. The Origins of Bone and Cartilage Disease Programme analysed the skeletal phenotype of knockout mice generated by the International Mouse Phenotyping Consortium (IMPC) and was funded by a Wellcome Trust Strategic Award (101123) to GW and JB. OM is funded by the Sigrid Jusélius Foundation. DG and SB declare that this study received funding from MINECO (SAF2016-75948R and PID2019-107188RB-C21). The funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Regulation of WNT16 in bone may involve upstream enhancers within CPED1

  • Martínez-Gil, Núria
  • Herrera-Úbeda, Carlos
  • Gritti, Nicola
  • Roca Ayats, Neus
  • Ugartondo, Nerea
  • Garcia Giralt, Natàlia
  • Ovejero Crespo, Diana
  • Nogués Solán, Xavier
  • Garcia-Fernàndez, Jordi
  • Grinberg, Daniel
  • Balcells, Susana
WNT16 stands up as an essential gene for bone homeostasis. Here, we present new evidence of the functional role of a particular region within WNT16. Performing 4 C chromatin conformation analysis in three osteoblast-related cells (the human fetal osteoblast hFOB 1.19 cell line, Saos 2 osteosarcoma cell line and mesenchymal Stem Cells -MSC-), we identify physical interactions between the proximal part of WNT16 intron 2, shown here to be an active promoter in Saos 2 osteosarcoma cells, and several putative regulatory regions within CPED1. Analysis of previously published RNA-seq data from hFOB cells disclosed low expression of a region located downstream of this promoter. Our results suggest a novel regulatory mechanism of WNT16 in bone, mediated by physical interaction with various enhancer regions within CPED1., Funds for the study include grants PID2019-107188RB-C21, PID2020-117820GB-I00, PID2022-141461OB-I00, PID2023-146794NB-I00 and BFU2017-86152-P (Spanish MINECO), 2021SGR: 01093 (AGAUR, Catalan Government) and CIBERER (U720). NMG was a recipient of a FI predoctoral fellowship from Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR); NRA was a recipient of a FPU and CHU of a FPI predoctoral fellowship from the Spanish Ministerio de Educación Cultura y Deporte.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Identifying rare variants in genes related to bone phenotypes in a cohort of postmenopausal women

  • Patiño, Juan David
  • Ovejero Crespo, Diana
  • Gabernet, Marc
  • Martínez-Gil, Núria
  • Alcaide-Consuegra, Estefanía
  • Mellibovsky, Leonardo
  • Nogués Solán, Xavier
  • Grinberg, Daniel
  • Balcells, Susana
  • Rabionet Janssen, Raquel
  • Garcia Giralt, Natàlia
Rare genetic variants in genes previously described to be involved in bone monogenic disorders were identified in postmenopausal women split into two groups according to extreme bone mineral density (BMD) values and lumbar spine Z-scores. A pathogenic variant in COL1A2 gene found in a woman with low BMD highlights the overlap between osteogenesis imperfecta and osteoporosis, which may share their genetic etiology. Other variants were not clearly associated with the extreme BMD, suggesting that there is little contribution of rare variants to postmenopausal osteoporosis. Purpose: We aimed to evaluate whether extreme values of bone mineral density (BMD) in a population-based cohort of postmenopausal women (BARCOS) could be determined by rare genetic variants in genes related to monogenic bone disorders. Methods: A panel of 127 genes related to different skeletal phenotypes was designed. Massive sequencing by targeted capture of these genes was performed in 104 DNA samples from those women of the BARCOS cohort that exhibited the highest (HZ group) and lowest (LZ group) LS Z-scores, ranging from + 0.70 to + 3.80 and from - 2.35 to - 4.26, respectively. 5'UTR, 3'UTR, splice region, missense, nonsense, and short indel variants with MAF < 0.01 were annotated with CADD version 1.6 and considered in the analysis. Results: After filtering those variants with CADD > 25 and present only in one of the groups (either LZ or HZ), six variants were detected, most of which (5/6) were in the LZ group in TCIRG1, COL1A2, SEC24D, LRP4, and ANO5 genes, while only one, in the LMNA gene, was in the HZ group. According to the ClinVar database, the COL1A2 variant, causative of a recessive form of osteogenesis imperfecta, is described as pathogenic, while the other variants are considered of uncertain significance (VUS). Conclusion: The variant identified in COL1A2 in a woman from the LZ group highlights the genetic overlap between monogenic diseases such as osteogenesis imperfecta and complex diseases like osteoporosis. However, the other variants were not clearly associated with the extreme BMD, suggesting that there is little contribution of rare variants to postmenopausal osteoporosis., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. Funds for the study include grants PID2019-107188RB-C21 (Spanish MICINN) and CIBERER (U720). JDP was a recipient of the FI-SDUR predoctoral fellowship from Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR). The research was also supported by the Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (grant number CB16/10/00245) and European Union Fund. DO is recipient of a Miquel Servet grant from ISCIII.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures

  • Garcia Giralt, Natàlia
  • Ovejero Crespo, Diana
  • Grinberg, Daniel
  • Nogués Solan, Francesc Xavier
  • Castañeda, Santos
  • Balcells, Susana
  • Rabionet Janssen, Raquel
Background: Recent studies suggested that genetic variants associated with monogenic bone disorders were involved in the pathogenesis of atypical femoral fractures (AFF). Here, we aim to identify rare genetic variants by whole exome sequencing in genes involved in monogenic rare skeletal diseases in 12 women with AFF and 4 controls without any fracture. Results: Out of 33 genetic variants identified in women with AFF, eleven (33.3%) were found in genes belonging to the Wnt pathway (LRP5, LRP6, DAAM2, WNT1, and WNT3A). One of them was rated as pathogenic (p.Pro582His in DAAM2), while all others were rated as variants of uncertain significance according to ClinVar and ACMG criteria. Conclusions: Osteoporosis, rare bone diseases, and AFFs may share the same genes, thus making it even more difficult to identify unique risk factors., This research was funded by Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (grant number CB16/10/00245); Fundación Española de Investigación Ósea y del Metabolismo Mineral (FEIOMM); Fondo de Investigación en Salud (grant number PI19/00033) from Instituto de Salud Carlos III (ISCIII) and European Union Fund. The research was also supported by MCIN/AEI/https://doi.org/10.13039/501100011033, Project PID2019-107188RB-C21, and AGAUR. DO is recipient of a Miquel Servet grant from ISCIII.